These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1943434)

  • 1. Rebound cue state following a single dose of haloperidol.
    Caul WF; Jones JR; Schmidt TA; Murphy SM; Barrett RJ
    Life Sci; 1991; 49(17):PL119-24. PubMed ID: 1943434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination.
    Stadler JR; Caul WF; Barrett RJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol.
    Barrett RJ; Steranka LR
    Pharmacol Biochem Behav; 1983 Apr; 18(4):611-7. PubMed ID: 6867066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound responding following a single dose of drug using an amphetamine-vehicle-haloperidol drug discrimination.
    Caul WF; Barrett RJ; Huffman EM; Stadler JR
    Psychopharmacology (Berl); 1996 Dec; 128(3):274-9. PubMed ID: 8972547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
    Barrett RJ; Caul WF; Stadler JR; Smith RL
    Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-induced withdrawal responding: effects of repeated drug administration.
    Caul WF; Stadler JR; Barrett RJ
    Psychopharmacology (Berl); 1997 Oct; 133(4):351-5. PubMed ID: 9372534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
    Haenlein M; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D; Thisted RA; Nichols DE
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine cue in rats as it relates to subjective drug effects: a preliminary report.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Eur J Pharmacol; 1976 Nov; 40(1):195-9. PubMed ID: 991926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol-induced supersensitivity to the discrimination of apomorphine.
    Schechter MD
    Eur J Pharmacol; 1981 Sep; 74(4):343-6. PubMed ID: 7297600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance, withdrawal, and supersensitivity to dopamine mediated cues in a drug-drug discrimination.
    Barrett RJ; White DK; Caul WF
    Psychopharmacology (Berl); 1992; 109(1-2):63-7. PubMed ID: 1365673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task.
    Barrett RJ; Caul WF; Smith R
    Pharmacol Biochem Behav; 2005 May; 81(1):1-8. PubMed ID: 15894057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of drug discrimination history on the generalization of pentobarbital to other drugs.
    McMillan DE; Sun WL; Hardwick WC
    J Pharmacol Exp Ther; 1996 Jul; 278(1):50-61. PubMed ID: 8764335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol on cue-induced autonomic and behavioral indices of heroin reward and motivation.
    Ettenberg A; McFarland K
    Psychopharmacology (Berl); 2003 Jul; 168(1-2):139-145. PubMed ID: 12420153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anorectic drugs in rats trained to discriminate between satiation and deprivation.
    Schechter MD
    Life Sci; 1990; 47(1):17-24. PubMed ID: 2388514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discrimination training during chronic drug treatment affects the development of tolerance.
    Caul WF; Burgin KL; Barrett RJ
    Behav Neurosci; 1989 Apr; 103(2):373-7. PubMed ID: 2706080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catatonic behavior induced by haloperidol, increased by retesting and elicited without drug in rats.
    de Sousa Moreira LF; Pinheiro MC; Masur J
    Pharmacology; 1982; 25(1):1-5. PubMed ID: 6889747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the dopamine autoreceptor antagonist (-)-DS121 on the discriminative stimulus properties of d-amphetamine and cocaine.
    Clark D; Exner M; Furmidge LJ; Svensson K; Sonesson C
    Eur J Pharmacol; 1995 Feb; 275(1):67-74. PubMed ID: 7774664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidol.
    Schmidt WJ; Krähling H; Ruhland M
    Life Sci; 1987 Oct; 41(16):1909-14. PubMed ID: 2889124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.